Ronixone-S 750 Injection
Marketer
Ronish Bioceuticals
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Ronixone-S 750 Injection
Cefixime and Sulbactam 750mg injection is a dual-action antibiotic. It's indicated for a range of bacterial infections, effectively inhibiting microbial growth and preventing infection spread. Administration must be strictly under medical guidance. Complete the prescribed treatment regimen, even with symptom improvement; premature cessation may reduce its effectiveness. Possible side effects include nausea, vomiting, diarrhea, and dyspepsia. Report worsening side effects immediately to your physician. Seek emergency medical attention for allergic reactions such as rashes, itching, swelling, or breathing difficulties. Inform your doctor of all other medications you're taking, including those for pre-existing conditions. Pregnant or lactating individuals should consult their doctor prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While driving ability isn't usually affected, avoid driving if drowsiness or dizziness occurs. Adequate rest, a nutritious diet, and sufficient hydration contribute to faster recovery. Your doctor may order blood tests and other diagnostic procedures to monitor treatment efficacy.
Primary Ingredients of Ronixone-S 750 Injection
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Ronixone-S 750 Injection
Infections caused by bacteria
Major Benefits of Ronixone-S 750 Injection:
The medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Ronixone-S 750 Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Ronixone-S 750 Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Ronixone-S 750 Injection works:
Ronixone-S 750 Injection combines the antibiotic Ceftriaxone with the beta-lactamase inhibitor Sulbactam. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Sulbactam counters bacterial resistance mechanisms, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of alcohol and Ronixone-S 750 Injection.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Ronixone-S 750 is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; yet, data from human trials remain scarce.
Breast feedingCAUTION
Administering Ronixone-S 750 Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Ronixone-S 750 Injection can induce drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if such effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Ronixone-S 750 Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Administering Ronixone-S 750 Injection requires careful consideration in individuals with severe hepatic impairment; dosage modification may be necessary. A physician's consultation is advised. Dosage alterations for Ronixone-S 750 Injection are unnecessary for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Ronixone-S 750 Injection :
Omitting a scheduled Ronixone-S 750 Injection necessitates contacting your physician.
Facts to Know About Ronixone-S 750 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently